Skip to Main Content
Skip Nav Destination

Issues

Acta Haematologica 2019, Vol. 142, No. 3

Editorial Comment

Subject Area: Hematology , Oncology
Acta Haematol (2019) 142 (3): 123–124. https://doi.org/10.1159/000497431

Review

Subject Area: Hematology , Oncology
Acta Haematol (2019) 142 (3): 125–131. https://doi.org/10.1159/000498937

Original Paper

Subject Area: Hematology , Oncology
Acta Haematol (2019) 142 (3): 132–141. https://doi.org/10.1159/000495453
Subject Area: Hematology , Oncology
Acta Haematol (2019) 142 (3): 142–148. https://doi.org/10.1159/000497404
Subject Area: Hematology , Oncology
Acta Haematol (2019) 142 (3): 149–153. https://doi.org/10.1159/000499101
Subject Area: Hematology , Oncology
Acta Haematol (2019) 142 (3): 154–161. https://doi.org/10.1159/000499102
Subject Area: Hematology , Oncology
Acta Haematol (2019) 142 (3): 162–170. https://doi.org/10.1159/000499065
Subject Area: Hematology , Oncology
Acta Haematol (2019) 142 (3): 171–175. https://doi.org/10.1159/000502374

Brief Communication

Subject Area: Hematology , Oncology
Acta Haematol (2019) 142 (3): 176–184. https://doi.org/10.1159/000495456

Rapid Communication

Subject Area: Hematology , Oncology
Acta Haematol (2019) 142 (3): 185–186. https://doi.org/10.1159/000497137

Letter to the Editor

Subject Area: Hematology , Oncology
Acta Haematol (2019) 142 (3): 187–189. https://doi.org/10.1159/000498906
Subject Area: Hematology , Oncology
Acta Haematol (2019) 142 (3): 190–192. https://doi.org/10.1159/000499100
Close Modal

or Create an Account

Close Modal
Close Modal